Diamonds and Dogs
12/10/14Calithera Biosciences Inc. (CALA)
Calithera Biosciences was painting the tape green today, up 29.88% to $17.17. The biopharmaceutical company saw its shares skyrocket after positive trial news. Calithera announced results of studies with primary human breast tumors that support glutaminase as a potential target in triple negative breast cancer (TNBC). The company's drug, CB-839 was demonstrated in primary TNBC tumor lysates as well as in tumors from a TNBC xenograft model. In addition, glutaminase inhibition of 75-84% was observed in tumor biopsy samples from three solid tumor patients enrolled in early dose cohorts of the ongoing phase I clinical trial. Shares of Calithera climbed nearly $4.00 today to a new 52-week high of $17.94 intraday.
Mitcham Industries Inc. (MIND)
Mitcham Industries is experiencing an earthquake today, getting shook down 20.14% to $5.71. The seismic and geophysical equipment manufacturer saw it shares fall after reporting a worse than expected third quarter. For the quarter, Mitcham management announced a loss of $397.000 or -$0.03 per share, on revenue of $22.9 million. The worse than expected quarter seems to be scaring off investors today, and has added to Mitcham's 60% decline this year. Shares of Mitcham fell nearly $1.50 today to a new 52-week low of $5.71.